Purchase Order W81K0223P0061
Award Date
10/1/23
Potential Completion Date
9/30/26
Potential Value
$66K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Immucor Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Norcross, GA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $61,238.20 firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Immucor Inc. for the delivery of blood bank reagents. The contract has an ultimate completion date of October 1, 2027. Immucor, a manufacturer of in vitro diagnostic products for transfusion and transplantation testing, was awarded this sole source contract under FAR 13.106-1 based on its specialized capabilities and proprietary solutions. The contract is not associated with a federal...
This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products, specifically blood typing, compatibility testing, and antibody screening reagents and consumables. The $137,483.05 contract has an ultimate completion date of December 31, 2027 and does not utilize any set-aside designations. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare...
This is a delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit organization and manufacturer of in vitro diagnostic reagents, test kits, and blood banking supplies. The $145,046.75 contract is for the provision of blood bank reagents and is issued under Immucor's General Services Administration (GSA) Multiple Award Schedule contract for in vitro diagnostics, reagents, and tests. The award does not utilize a set-aside designation. Immucor has a history of...
This contract award to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, is for the delivery of blood reagents, test kits, and diagnostic products to support the testing programs and healthcare services of the Defense Health Agency (DHA). The $260,536.03 firm fixed-price delivery order was issued under Immucor's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and test kits. The award does not have a...
This is a firm-fixed price supply contract awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract, valued at $1,016,206.99, is for the delivery of consumable reagents used for blood typing, antibody screening, and identifying compatible blood products for transfusion. The contract has a base period of one year from October 1, 2023 to September 30, 2024, with four one-year option periods. The original...
This federal contract award is for the delivery of blood bank reagents to support the operations of the Defense Health Agency (DHA) from June 13, 2024 to September 30, 2024. The $35,616.26 firm fixed price delivery order was awarded to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products and blood banking supplies. Immucor has previously held multiple award schedule contracts and other federal awards with agencies such as the Department of Veterans Affairs and Indian Health...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products used for blood testing and compatibility screening. The $223,928.56 contract is for the provision of various medical supplies and reagents used to test for the compatibility of blood products. The contract was awarded under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests and does not have a set-aside...
This is a $91,866.32 firm fixed price delivery order contract awarded to Immucor Inc. by the Department of Defense's Bureau of Medicine and Surgery (BUMED). The contract is for the provision of blood reagents and is placed against Immucor's existing GSA Federal Supply Schedule (FSS) contract for in vitro diagnostics, reagents, and test kits. No set-aside was used for this award. Immucor is a leading provider of automated instrument-reagent systems, consumables, and services for blood transfusion...